SHANGHAI, CHINA / ACCESSWIRE / April 5, 2023 / On March 31, 2023, Forecyte Bio held its opening ceremony for its brand-new, state-of-the-art Cell and Gene Therapy GMP facility in Shanghai, China, ...

FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet, ...

Cytiva and Forecyte Bio announced on August 25, 2022 that they will collaborate to accelerate the manufacturing and development of the cell and gene therapy industry in China and the United States.

Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States. Forecyte Bio held an opening ceremony on March 31, 2023, for its new cell and gene ...

Atossa is partnering with Thermo Fisher to expand its ForeCYTE breast health diagnostic.--Courtesy of Atossa Atossa Genetics ($ATOS) has been steadily expanding the ...

Atossa Genetics has recalled its ForeCYTE breast health diagnostic.--Courtesy of Atossa Genetics The FDA has applied its most serious label to Atossa Genetics' ($ATOS ...

SEATTLE, WA--(Marketwired - Sep 23, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast Aspirator ...

Forecyte Bio, a CGT CDMO, Hosted a Grand Opening for its Brand New GMP Facility in Shanghai, Just Two Months After its Sister Site in the United States SHANGHAI, April 5, 2023 (Newswire.com) - On ...